Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000863963 | SCV001004699 | likely benign | Brugada syndrome | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363219 | SCV002625274 | likely benign | Cardiovascular phenotype | 2020-05-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001701456 | SCV001922502 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724178 | SCV001958724 | likely benign | not provided | no assertion criteria provided | clinical testing |